Health Canada has approved skin health (or ‘beauty from within,’ as the industry calls it) claims for two different doses of Ceramosides, the commercial name of Seppic’s branded phytoceramides derived from wheat.
The 30 mg dose in powder form, registered with the Natural Product Number (NPN) 80090999, may be marketed with the recommended use or purpose of helping “improve skin hydration,” “help to improve skin smoothness and appearance for a health skin,” “improves skin elasticity and moisture,” and “helps to support skin health.”
Additionally, products using the ingredient with the appropriate dose may be marketed using claims that say the effects may be seen in 15 days.
A higher dose, at 70 mg per serving in oil form, is approved for the same claims as the 30 mg dose.
“We saw a growing interest from our Canadian customers for the beauty-from-within category and Ceramosides more specifically,” said Sebastien Merchet, business development manager for Seppic’s North America business.
“Thanks to these NPN numbers with associated claims, our customers using Ceramosides can now register their finished products in a shorter period of time and drastically reduce the time-to-market of their launches.”
The ingredient was developed in collaboration with E.P.I. France, with Seppic taking charge for marketing the ingredient and making sure it goes through appropriate regulatory measures in different markets.
In 2017, researchers from E.P.I. France’s R&D department published a study in the journal Cosmetics, reporting a positive link between oral supplementation of ceramides on skin parameters in humans.
“Thanks to the strong and trusted scientific backing behind Ceramosides, we are glad to bring to our customers in Canada unique and innovatve claims for the growing beauty-from-within category,” Merchet said.
There is a growing trend among formulators to develop beauty-from-within products using plant-based ingredients, as the ingestible beauty category’s star ingredient collagen has now vegetarian alternative.